Mage antigenic peptides which bind hla-b35 and hla-b44
作者： Vincent Stroobant , Pierre Van Der Bruggen , Rosalie Luiten , Erwin Schultz , Thierry Boon-Falleur
DOI:
关键词:
摘要: The invention provides antigenic peptides derived from MAGE-A1 polypeptides and presented by HLA-B35 HLA-B44 molecules. Antigenic MAGE-A3 molecules also are provided. Methods for diagnosis treatment which involve the
lens.org 参考文章(10)
Christophe Lurquin, Pierre van der Bruggen, Etienne De Plaen, Catia Traversari, Benoit Van den Eynde, Thierry Boon-Falleur, Beatrice Gaugler, Isolated nucleic acid molecules which encode MAGE derived nonapeptides ,(1993)
Danila Valmori, Frederic Lévy, Isabelle Miconnet, Paul Zajac, Giulio C. Spagnoli, Donata Rimoldi, Danielle Liénard, Vincenzo Cerundolo, Jean-Charles Cerottini, Pedro Romero, Induction of Potent Antitumor CTL Responses by Recombinant Vaccinia Encoding a Melan-A Peptide Analogue The Journal of Immunology. ,vol. 164, pp. 1125- 1131 ,(2000) , 10.4049/JIMMUNOL.164.2.1125
Catia Traversari, Pedro Romero, Den Eynde Benoit Van, Der Bruggen Pierre Van, Christoph Lurquin, Thierry Boon-Falleur, Plaen Etienne De, Beatrice Gaugler, Isolated nonapeptides presented by hla molecules, and uses thereof ,(1996)
Pierre van der Bruggen, Catia Traversari, Katharina Fleischauer, Thierry Boon-Falleur, Isolated, mage-3 derived peptides which complex with hla-a2 molecules and uses thereof ,(1995)
Danila Valmori, Jean-Charles Cerottini, Pedro Romero, Isolated nona- and decapeptides which bind to hla molecules, and the use thereof ,(1998)
Yannick Guilloux, Sophie Lucas, Thierry Boon-Falleur, Francine Jotereau, Vincent Brichard, Isolated nucleic acid molecules, peptides which form complexes with MHC molecule HLA-A2 and uses thereof ,(1996)
Immanuel Luescher, Pierre Coulie, Der Bruggen Pierre Van, Jean Herman, Thierry Boon-Falleur, Tumor rejection antigens presented by hla-b44 molecules, and uses thereof ,(1997)
Den Eynde Benoit Van, Der Bruggen Pierre Van, Olivier Debacker, Thierry Boon-Falleur, Isolated, polypeptides which bind to hla-a29 molecules, nucleic acid, the molecules encoding these, and uses thereof ,(1999)
Pierre Coulie, Bernard Lethe, Pel Aline Van, Plaen Etienne De, Thierry Boon-Falleur, Jean-Christophe Renault, Thomas Wolfel, Vincent Brichard, Methods for detection and treatment of individuals having abnormal cells expressing hla-a2/tyrosinase peptide antigens ,(1993)
Benoît Van Den Eynde, Sandra Morel, Thierry Boon-Falleur, Annie Ooms, Gérard De Giiovanni, Isolated peptides which bind to HLA-B35 molecules, larger peptides which contain these, nucleic acid molecules encoding peptides, and uses thereof ,(1998)